EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Botanical Sources: 12

Rose hip Rosa canina L.

Also called: rosehip, Rosa canina fruit

Rose hips are the fruits of the shrub Rosa canina. Trials have tested standardized rose hip powders, including one made from the seeds and shells of a Rosa canina subspecies, as well as rose hip extracts and powder drinks.

Category
Botanical
Part used
Fruit (hip), as powder or extract
Strongest evidence
B Some positive trials
Native range
Native from Madeira and northwest Africa through Europe to Central Asia and Pakistan (POWO: "Madeira, NW. Africa, Europe to Central Asia and Pakistan")
Reviewed
2026-10-30

Class 2 Moderately studied in people. A 2008 meta-analysis pooled three randomized controlled trials (287 patients with osteoarthritis) of rose hip powder versus placebo, all supported by the manufacturer. [1]

Fact-checked 2026-10-30 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

6 topics studied4 body areas · strongest grade B

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Rose hip does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Rose hip, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Osteoarthritis painBA 2008 meta-analysis of three placebo-controlled RCTs (287 patients, median 3 months) found reduced pain (effect size 0.37), with patients about twice as likely to respond (OR 2.19); all trials were manufacturer-supported, and independent replication was called for. [1]
Knee function during walkingCIn one 12-week RCT of 100 adults with knee-related walking limitations, rose hip powder capsules improved the peak resultant knee moment during walking versus placebo (0.06 Nm/kg). [5]
Rheumatoid arthritisCIn one 6-month RCT of 89 patients, 5 g/day rose hip powder improved a disability score (HAQ-DI) versus placebo; pain scores and pain-medication use did not differ. [3]
Blood pressure and cholesterol in obese adultsCIn a 6-week crossover RCT of 31 obese adults, a 40 g/day rose hip powder drink lowered systolic blood pressure by 3.4% and total cholesterol by 4.9% versus a control drink; weight and glucose tolerance did not differ. [4]
Urinary tract infection after cesarean deliveryCIn one RCT of 400 women, 500 mg Rosa canina fruit capsules twice daily for 20 days were followed by fewer positive urine cultures than placebo; cystitis incidence did not differ. [6]
Facial wrinkles and skin moistureCIn one 8-week randomized study of 34 adults, rose hip powder and the comparator astaxanthin both improved crow's-feet wrinkles, moisture and elasticity; there was no placebo group. [8]

Main constituents: Phenolics, terpenoids, galactolipids, carotenoids, fruit acids and fatty oils, besides vitamin C; the review considers their combination responsible for observed effects [2]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • 5 g/day of standardized rose hip powder for 3 months per period (osteoarthritis crossover trial). [7]
  • 5 g/day of capsulated rose hip powder for 6 months (rheumatoid arthritis trial). [3]
  • 40 g/day of rose hip powder in a drink for 6 weeks (obese adults). [4]
  • Two 500 mg capsules of rose hip fruit extract daily for 4 weeks (adults with type 2 diabetes and orthostatic hypotension). [9]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Pregnancy and breastfeeding
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Interactions with medicines
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    None on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    None found

    No published information found in the sources checked.

    Details and sources
  • In a 3-month crossover RCT of 112 osteoarthritis patients taking 5 g/day rose hip powder, no major side effects occurred in either group. [7]
  • Investigators described the extract as well tolerated in a 4-week RCT of 60 adults with type 2 diabetes. [9]
  • The 2008 meta-analysis authors stated that efficacy and safety need evaluation in a future large-scale, long-term trial. [1]
Quality

Identity, quality and standardization

  • All three trials pooled in the 2008 meta-analysis were supported by the manufacturer (Hyben-Vital International). [1]
  • The German Commission E gave rose hip, rose hip and seed, and rose hip seed negative monographs because of insufficient evidence of effects. [12]
Regulation

Regulatory status

  • US: by law, FDA does not approve dietary supplements or their labeling before they are marketed. [10]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Phenolics, terpenoids, galactolipids, carotenoids, fruit acids and fatty oils, besides vitamin C (considered together responsible for effects) Mixed: phenolics, terpenoids, galactolipids, carotenoids [P2]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • No NDI notification naming rose hip (Rosa canina) was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P5]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC evaluation of rose hip (Rosa canina) was found (IARC Monographs list of classifications, Volumes 1-142, checked 2026-10-29). [P7]
  • No NTP technical report on rose hip (Rosa canina) was found (NTP technical reports list checked 2026-10-29). [P8]

Liver (NIH LiverTox)

  • No published information found in the sources checked.

Interactions with medicines

  • No published information found in the sources checked.

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity test or examination of each dietary-ingredient component — US cGMP rule for dietary supplements: at least one appropriate test or examination must verify the identity of any component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)); exemption only through a petition FDA grants (111.75(a)(1)(ii)). [P6]

Supply and conservation

  • No published information found in the sources checked.

Absorption in people

  • No published information found in the sources checked.

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • No published information found in the sources checked.

Pregnancy and breastfeeding

  • No published information found in the sources checked.

Sources for this profile

  1. Christensen R, Bartels EM, Altman RD, Astrup A, Bliddal H. Does the hip powder of Rosa canina (rosehip) reduce pain in osteoarthritis patients? A meta-analysis of randomized controlled trials. Osteoarthritis Cartilage 2008;16(9):965-72 (PMID 18407528), 2008-09. pubmed.ncbi.nlm.nih.gov
  2. Gruenwald J, Uebelhack R, Moré MI. Rosa canina - rose hip pharmacological ingredients and molecular mechanics counteracting osteoarthritis: a systematic review. Phytomedicine 2019;60:152958 (PMID 31138475), 2019-07. pubmed.ncbi.nlm.nih.gov
  3. Rein E, Kharazmi A, Winther K. A herbal remedy, Hyben Vital (stand. powder of a subspecies of Rosa canina fruits), reduces pain and improves general wellbeing in patients with osteoarthritis: a double-blind, placebo-controlled, randomised trial. Phytomedicine 2004;11(5):383-91 (PMID 15330493), 2004-07. pubmed.ncbi.nlm.nih.gov
  4. Ghelmani SY, et al. Effects of rosehip (Rosa canina) supplementation on orthostatic intolerance symptoms in patients with type 2 diabetes: a randomized double-blind placebo-controlled clinical trial. Daru 2026;34(2):90 (PMID 42831964), 2026-10-05. pubmed.ncbi.nlm.nih.gov
  5. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  6. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
  7. IARC Monographs. List of Classifications: agents classified by the IARC Monographs, Volumes 1-142 (last updated 2026-07-23; checked 2026-10-29), 2026-07-23. monographs.iarc.who.int
  8. National Toxicology Program (NIEHS). Technical Reports list, TR-001 to TR-606 (checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
Sources

Sources

  1. Christensen R, Bartels EM, Altman RD, Astrup A, Bliddal H. Does the hip powder of Rosa canina (rosehip) reduce pain in osteoarthritis patients? A meta-analysis of randomized controlled trials. Osteoarthritis Cartilage 2008;16(9):965-72 (PMID 18407528), 2008-09. pubmed.ncbi.nlm.nih.gov
  2. Gruenwald J, Uebelhack R, Moré MI. Rosa canina - rose hip pharmacological ingredients and molecular mechanics counteracting osteoarthritis: a systematic review. Phytomedicine 2019;60:152958 (PMID 31138475), 2019-07. pubmed.ncbi.nlm.nih.gov
  3. Willich SN, et al. Rose hip herbal remedy in patients with rheumatoid arthritis: a randomised controlled trial. Phytomedicine 2010;17(2):87-93 (PMID 19818588), 2010-02. pubmed.ncbi.nlm.nih.gov
  4. Andersson U, et al. Effects of rose hip intake on risk markers of type 2 diabetes and cardiovascular disease: a randomized, double-blind, cross-over investigation in obese persons. Eur J Clin Nutr 2012;66(5):585-90 (PMID 22166897), 2012-05. pubmed.ncbi.nlm.nih.gov
  5. Ginnerup-Nielsen E, et al. Improved gait in persons with knee related mobility limitations by a rosehip food supplement: a randomized, double-blind, placebo-controlled trial. Gait Posture 2015;42(3):340-7 (PMID 26234471), 2015-09. pubmed.ncbi.nlm.nih.gov
  6. Seifi M, et al. The effect of Rosa (L. Rosa canina) on the incidence of urinary tract infection in the puerperium: a randomized placebo-controlled trial. Phytother Res 2018;32(1):76-83 (PMID 29024081), 2018-01. pubmed.ncbi.nlm.nih.gov
  7. Rein E, Kharazmi A, Winther K. A herbal remedy, Hyben Vital (stand. powder of a subspecies of Rosa canina fruits), reduces pain and improves general wellbeing in patients with osteoarthritis: a double-blind, placebo-controlled, randomised trial. Phytomedicine 2004;11(5):383-91 (PMID 15330493), 2004-07. pubmed.ncbi.nlm.nih.gov
  8. Phetcharat L, Wongsuphasawat K, Winther K. The effectiveness of a standardized rose hip powder, containing seeds and shells of Rosa canina, on cell longevity, skin wrinkles, moisture, and elasticity. Clin Interv Aging 2015;10:1849-56 (PMID 26604725), 2015-11-19. pubmed.ncbi.nlm.nih.gov
  9. Ghelmani SY, et al. Effects of rosehip (Rosa canina) supplementation on orthostatic intolerance symptoms in patients with type 2 diabetes: a randomized double-blind placebo-controlled clinical trial. Daru 2026;34(2):90 (PMID 42831964), 2026-10-05. pubmed.ncbi.nlm.nih.gov
  10. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
  11. Plants of the World Online (POWO), Royal Botanic Gardens, Kew; WCVP data. Rosa canina L. (accessed 2026-10-29), 2026-10-29. powo.science.kew.org
  12. Chrubasik C, Roufogalis BD, Müller-Ladner U, Chrubasik S. A systematic review on the Rosa canina effect and efficacy profiles. Phytother Res 2008;22(6):725-33 (PMID 18384191), 2008-06. pubmed.ncbi.nlm.nih.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.